3.0.0
3503
2024-12-06T09:05:35Z
2024-12-06T09:05:35Z
House
H
HR
2023-05-18
118
[Congressional Record Volume 169, Number 84 (Thursday, May 18, 2023)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. KELLY of Illinois:H.R. 3503.Congress has the power to enact this legislation pursuantti following:Article I, Section 8, clause 18The single subject of this legislation is:NIH Clinical Trial Diversity Bill[Page H2458]
- hsif00
Energy and Commerce Committee
House
Standing
  - hsif14
Health Subcommittee
    - Referred to
2023-05-19T18:08:42Z
  - Referred to
2023-05-18T13:05:50Z
- 2023-05-19
  - hsif14
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2023-05-18
Referred to the House Committee on Energy and Commerce.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2023-05-18
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2023-05-18
Introduced in House
IntroReferral
1000
9
Library of Congress
- K000385
Rep. Kelly, Robin L. [D-IL-2]
Robin
Kelly
D
IL
L.
2
N
- F000466
Rep. Fitzpatrick, Brian K. [R-PA-1]
Brian
Fitzpatrick
R
PA
K.
1
2023-05-18
True
- N000147
Del. Norton, Eleanor Holmes [D-DC-At Large]
ELEANOR
NORTON
D
DC
HOLMES
0
2023-05-31
False
- M001160
Rep. Moore, Gwen [D-WI-4]
Gwen
Moore
D
WI
4
2023-05-31
False
- E000215
Rep. Eshoo, Anna G. [D-CA-16]
ANNA
ESHOO
D
CA
G.
16
2023-05-31
False
- W000797
Rep. Wasserman Schultz, Debbie [D-FL-25]
Debbie
Wasserman Schultz
D
FL
25
2023-06-12
False
- B001300
Rep. Barragan, Nanette Diaz [D-CA-44]
Nanette
Barragan
D
CA
Diaz
44
2023-06-21
False
- C001067
Rep. Clarke, Yvette D. [D-NY-9]
Yvette
Clarke
D
NY
D.
9
2023-07-06
False
- A000370
Rep. Adams, Alma S. [D-NC-12]
Alma
Adams
D
NC
S.
12
2023-07-06
False
- P000616
Rep. Phillips, Dean [D-MN-3]
Dean
Phillips
D
MN
3
2023-07-06
False
- C001097
Rep. Cárdenas, Tony [D-CA-29]
Tony
Cárdenas
D
CA
29
2023-07-10
False
- J000298
Rep. Jayapal, Pramila [D-WA-7]
Pramila
Jayapal
D
WA
7
2023-07-10
False
- A000376
Rep. Allred, Colin Z. [D-TX-32]
Colin
Allred
D
TX
Z.
32
2023-07-18
False
- K000375
Rep. Keating, William R. [D-MA-9]
William
Keating
D
MA
R.
9
2023-08-04
False
- C001117
Rep. Casten, Sean [D-IL-6]
Sean
Casten
D
IL
6
2023-08-11
False
- L000582
Rep. Lieu, Ted [D-CA-36]
Ted
Lieu
D
CA
36
2023-09-12
False
- P000607
Rep. Pocan, Mark [D-WI-2]
Mark
Pocan
D
WI
2
2023-09-12
False
- P000620
Rep. Pettersen, Brittany [D-CO-7]
Brittany
Pettersen
D
CO
7
2023-09-26
False
- B001303
Rep. Blunt Rochester, Lisa [D-DE-At Large]
Lisa
Blunt Rochester
D
DE
0
2023-09-26
False
- H001047
Rep. Himes, James A. [D-CT-4]
James
Himes
D
CT
A.
4
2023-09-26
False
- J000288
Rep. Johnson, Henry C. "Hank," Jr. [D-GA-4]
Henry
Johnson
D
GA
C. "Hank"
4
2023-09-26
False
- W000822
Rep. Watson Coleman, Bonnie [D-NJ-12]
Bonnie
Watson Coleman
D
NJ
12
2023-10-11
False
- M001223
Rep. Magaziner, Seth [D-RI-2]
Seth
Magaziner
D
RI
2
2023-10-11
False
- T000487
Rep. Tokuda, Jill N. [D-HI-2]
Jill
Tokuda
D
HI
N.
2
2023-10-19
False
- C001134
Rep. Caraveo, Yadira [D-CO-8]
Yadira
Caraveo
D
CO
8
2023-10-26
False
- K000394
Rep. Kim, Andy [D-NJ-3]
Andy
Kim
D
NJ
3
2023-11-29
False
- G000583
Rep. Gottheimer, Josh [D-NJ-5]
Josh
Gottheimer
D
NJ
5
2024-02-29
False
- J000032
Rep. Jackson Lee, Sheila [D-TX-18]
Sheila
Jackson Lee
D
TX
18
2024-03-26
False
- N000191
Rep. Neguse, Joe [D-CO-2]
Joe
Neguse
D
CO
2
2024-03-29
False
- M001206
Rep. Morelle, Joseph D. [D-NY-25]
Joseph
Morelle
D
NY
D.
25
2024-04-23
False
- L000562
Rep. Lynch, Stephen F. [D-MA-8]
Stephen
Lynch
D
MA
F.
8
2024-05-06
False
- D000623
Rep. DeSaulnier, Mark [D-CA-10]
Mark
DeSaulnier
D
CA
10
2024-05-06
False
- P000608
Rep. Peters, Scott H. [D-CA-50]
Scott
Peters
D
CA
H.
50
2024-05-06
False
- B001318
Rep. Balint, Becca [D-VT-At Large]
Becca
Balint
D
VT
0
2024-05-06
False
- N000179
Rep. Napolitano, Grace F. [D-CA-31]
Grace
Napolitano
D
CA
F.
31
2024-05-06
False
- C001121
Rep. Crow, Jason [D-CO-6]
Jason
Crow
D
CO
6
2024-05-21
False
- M001227
Rep. McClellan, Jennifer L. [D-VA-4]
Jennifer
McClellan
D
VA
L.
4
2024-05-21
False
- T000469
Rep. Tonko, Paul [D-NY-20]
Paul
Tonko
D
NY
20
2024-05-22
False
- P000619
Rep. Peltola, Mary Sattler [D-AK-At Large]
Mary
Peltola
D
AK
Sattler
0
2024-06-13
False
- N000002
Rep. Nadler, Jerrold [D-NY-12]
Jerrold
Nadler
D
NY
12
2024-08-09
False
- S001218
Rep. Stansbury, Melanie A. [D-NM-1]
Melanie
Stansbury
D
NM
A.
1
2024-12-05
False
Health
- Congressional oversight
2023-07-14T12:45:29Z
- Government information and archives
2023-07-14T12:45:29Z
- Government studies and investigations
2023-07-14T12:45:29Z
- Health information and medical records
2023-07-14T12:45:29Z
- Medical research
2023-07-14T12:45:29Z
- Minority health
2023-07-14T12:45:29Z
- National Institutes of Health (NIH)
2023-07-14T12:45:29Z
- Research administration and funding
2023-07-14T12:45:29Z
- Women's health
2023-07-14T12:45:29Z
Health
2023-06-14T18:30:24Z
00
2023-05-18
Introduced in House
2024-02-23T18:03:13Z
NIH Clinical Trial Diversity Act of 2023
This bill sets out requirements to increase the diversity of clinical trial participants and requires other activities to foster participation in clinical trials.
As a condition of approval from the National Institutes of Health (NIH) for a clinical trial investigating a drug, device, or behavioral intervention, a sponsor's application must include certain information related to diversity in its trial, such as
- goals for recruiting and retaining trial participants,
- plans for achieving the recruitment and retention goals and implementing less-burdensome clinical trial follow-up requirements, and
- requirements for researchers and other individuals involved with the trial to complete education and training about diversity in clinical trials.
A sponsor must also annually share demographic data of clinical trial participants with the NIH. The NIH must publish on its website information about the diversity of and other information concerning the clinical trials it funds.
If a sponsor fails to meet its diversity goals or related requirements, the sponsor must develop and implement a strategic plan to increase the diversity of the clinical trial participants.
Further, the NIH and the Food and Drug Administration must carry out a national campaign to increase awareness about the need for diverse clinical trials.
The bill also requires studies on barriers to participation in clinical trials. The Government Accountability Office must study actions taken by federal agencies to address such barriers while the NIH must study regulations that govern reimbursements of out-of-pocket expenses of and incentives for clinical trial participants.

NIH Clinical Trial Diversity Act of 2023
- Display Title
45

NIH Clinical Trial Diversity Act of 2023
2024-06-11T15:44:12Z
- Short Title(s) as Introduced
101

NIH Clinical Trial Diversity Act of 2023
2024-05-24T13:39:34Z
Introduced in House
IH
- Official Title as Introduced
6

To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes.
2024-03-18T20:50:14Z
Introduced in House
IH
- Introduced in House
2023-05-18T04:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-118hr3503ih/xml/BILLS-118hr3503ih.xml
2023-05-19
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.